|
Volumn 27, Issue 9, 2008, Pages 957-969
|
Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Lung and Heart/Lung Transplantation Report-2008
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR BLOCKING AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ACUTE GRAFT REJECTION;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
ARTICLE;
BRONCHIECTASIS;
BRONCHIOLITIS OBLITERANS;
CAUSE OF DEATH;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONGENITAL HEART DISEASE;
CONNECTIVE TISSUE DISEASE;
CYSTIC FIBROSIS;
EMPHYSEMA;
FIBROSING ALVEOLITIS;
HEART LUNG TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTERSTITIAL PNEUMONIA;
KAPLAN MEIER METHOD;
LUNG CANCER;
LUNG TRANSPLANTATION;
LYMPHANGIOLEIOMYOMATOSIS;
MEDICAL LITERATURE;
MORBIDITY;
MORTALITY;
MULTIVARIATE ANALYSIS;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RETRANSPLANTATION;
RISK FACTOR;
SARCOIDOSIS;
STATISTICAL ANALYSIS;
SURVIVAL;
TIME SERIES ANALYSIS;
TREATMENT INDICATION;
ADULT;
AGE DISTRIBUTION;
AGED;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HEART-LUNG TRANSPLANTATION;
HUMANS;
INTERNATIONAL COOPERATION;
LUNG TRANSPLANTATION;
MIDDLE AGED;
REGISTRIES;
RISK;
SOCIETIES, MEDICAL;
SURVIVAL ANALYSIS;
|
EID: 50249113840
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/j.healun.2008.07.018 Document Type: Article |
Times cited : (210)
|
References (0)
|